Journal of the Formosan Medical Association
Volume 105, Issue 2 , Pages 99-104 , 2006

Association of p53 Codon 72 Polymorphism with Risk of Hypopharyngeal Squamous Cell Carcinoma in Taiwan

  • Chih-Wen Twu

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei
    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Rong-San Jiang

      Affiliations

    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Chih-Hung Shu

      Affiliations

    • Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Jin-Ching Lin

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei
    • Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • Department of Radiation Oncology, National Cheng Kung University Hospital, Tainan, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr. Jin-Ching Lin, Department of Radiation Oncology, Taichung Veterans General Hospital, 160, Section 3, Taichung-Kang Road, Taichung 407, Taiwan, R.O.C.

Received 31 March 2005 ,Revised 2 May 2005 ,Accepted 7 June 2005.

References 

  1. Hoffman HT , Karnell LH , Shap JP , et al.   Hypopharyngeal cancer patient care evaluation . Laryngoscope . 1997;107:1005–1017
  2. Ahomadegbe JC , Barrois M , Fogel S , et al.   High incidence of p53 alterations (mutations, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions . Oncogene . 1995;10:1217–1227
  3. Hauser U , Balz V , Carey TE , et al.   Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region . Head Neck . 2002;24:868–873
  4. Matlashewski GJ , Tuck S , Pim D , et al.   Primary structure polymorphism at amino acid residue 72 of human p53 . Mol Cell Biol . 1987;7:961–963
  5. Storey A , Thomas M , Kalita A , et al.   Role of a p53 polymorphism in the development of human papillomavirus-associated cancer . Nature . 1998;393:229–234
  6. Madeleine MM , Shera K , Schwartz SM , et al.   The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer . Cancer Epidemiol Biomarkers Prev . 2000;9:225–227
  7. Tenti P , Vesentini N , Spaudo MR , et al.   p53 codon polymorphism does not affect the risk of cervical cancer in patients from northern Italy . Cancer Epidemiol Biomarkers Prev . 2000;9:435–438
  8. Andersson S , Rylander E , Strand A , et al.   The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas . Br J Cancer . 2001;85:1153–1156
  9. Zehbe I , Voglino G , Wilander E , et al.   Codon 72 polymorphism of p53 and its association with cervical cancer . Lancet . 1999;354:218–219
  10. Rosenthal AN , Ryan A , Al-Jehani RM , et al.   p53 codon 72 polymorphism and risk of cervical cancer in the UK . Lancet . 1998;352:871–875
  11. Sonoda Y , Saigo PE , Boyd J . p53 and genetic susceptibility to cervical cancer . J Natl Cancer Inst . 1999;91:557
  12. Papadakis ED , Soulitzis N , Spandidos DA . Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumors arising in Arg/Pro germline heterozygotes . Br J Cancer . 2002;87:1013–1018
  13. Murata M , Tagawa M , Kimura M , et al.   Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history . Carcinogenesis . 1996;17:261–264
  14. Jin X , Wu X , Roth JA , et al.   Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype . Carcinogenesis . 1995;16:2205–2208
  15. Fan R , Wu MT , Miller D , et al.   The p53 codon 72 polymorphism and lung cancer risk . Cancer Epidemiol Biomarkers Prev . 2000;9:1037–1042
  16. Liu G , Miller DP , Zhou W , et al.   Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma . Cancer Res . 2001;61:8718–8722
  17. Kawajiri K , Nakachi K , Imai K , et al.   Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer . Carcinogenesis . 1993;14:1085–1089
  18. Wang YC , Chen CY , Chen SK , et al.   p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis . Clin Cancer Res . 1999;5:129–134
  19. Chen WC , Tsai FJ , Wu JY , et al.   Distribution of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor . Urol Res . 2000;28:293–296
  20. Soulitzis N , Sourvinos G , Dokianakis DN , et al.   p53 codon polymorphism and its association with bladder cancer . Cancer Lett . 2002;179:175–183
  21. Toruner GA , Ucar A , Tez M , et al.   p53 codon 72 polymorphism in bladder cancer-no evidence of association with increased risk of invasiveness . Urol Res . 2001;29:393–395
  22. Henner WD , Evans AJ , Hough KM , et al.   Association of codon 72 polymorphism of p53 with lower prostate cancer risk . Prostate . 2001;49:263–266
  23. Chen YC , Xu L , Guo YL , et al.   Genetic polymorphism in p53 codon 72 and skin cancer in southwestern Taiwan . J Environ Sci Health (Part A) . 2003;38:201–211
  24. O'Connor DP , Kay EW , Leader M , et al.   p53 codon 72 polymorphism and human papillomavirus associated skin cancer . J Clin Pathol . 2001;54:539–542
  25. Kawaguchi H , Ohno S , Araki K , et al.   p53 polymorphism in human papillomavirus-associated esophageal cancer . Cancer Res . 2000;60:2753–2755
  26. Lee JM , Lee YC , Yang SY , et al.   Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous cell carcinoma of the esophagus . Int J Cancer . 2000;89:458–464
  27. Hiyama T , Tanaka S , Kitadai Y , et al.   p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis . Int J Cancer . 2002;100:304–308
  28. Buyru N , Tigli H , Dalay N . p53 codon 72 polymorphism in breast cancer . Oncol Rep . 2003;10:711–714
  29. Papadakis EN , Dokianakis DN , Spandidos DA . p53 codon 72 polymorphism as a risk factor in the development of breast cancer . Mol Cell Biol Res Commun . 2000;3:389–392
  30. Sjalander A , Birgrander R , Hallmans G , et al.   p53 polymorphisms and haplotypes in breast cancer . Carcinogenesis . 1996;17:1313–1316
  31. Hamel N , Black MJ , Ghadirian P , et al.   No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck . Br J Cancer . 2000;82:757–759
  32. McWilliams JE , Evans AJ , Beer TM , et al.   Genetic polymorphisms in head and neck cancer risk . Head Neck . 2000;22:609–617
  33. Shen H , Zheng Y , Sturgis EM , et al.   p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study . Cancer Lett . 2002;183:123–130
  34. Hollstein M , Sidransky D , Vogelstein B , et al.   p53 mutations in human cancers . Science . 1991;253:49–53
  35. Giaccia AJ , Kastan MB . The complexity of p53 modulation: emerging patterns from divergent signals . Gene Dev . 1998;12:2973–2983
  36. Vogelstein B , Kinsler K . p53 function and dysfunction . Cell . 1992;70:523–526
  37. Walker KK , Levine AJ . Identification of a novel p53 functional domain that is necessary for efficient growth suppression . Proc Natl Acad Sci USA . 1996;93:15335–15340
  38. Sakamuro D , Sabbatini P , White E , et al.   The polyproline region of p53 is required to activate apoptosis but not growth arrest . Oncogene . 1997;15:887–898
  39. Thomas M , Kalita A , Labrecque S , et al.   Two polymorphic variants of wild-type p53 differ biochemically and biologically . Mol Cell Biol . 1999;19:1092–1100
  40. Marin MC , Jost CA , Brooks LA , et al.   A common polymorphism acts as an intragenic modifier of mutant p53 behavior . Nat Genet . 2000;25:47–54
  41. Brooks LA , Tidy JA , Gusterson B , et al.   Preferential retention of codon 72 arginine in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus . Cancer Res . 2000;60:6875–6877
  42. Koushik A , Platt RW , Franco EL . p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review . Cancer Epidemiol Biomarkers Prev . 2004;13:11–22
  43. Matakidou A , Eisen T , Houlston RS . TP53 polymorphisms and lung cancer risk: a systemic review and meta-analysis . Mutagenesis . 2003;18:377–385
  44. Summersgill KF , Smith EM , Kirchner HL , et al.   p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2000;90:334–339
  45. Tandle AT , Sanghvi V , Saranath D . Determination of p53 genotypes in oral cancer patients from India . Br J Cancer . 2001;84:739–742
  46. Tsai MH , Lin CD , Hsieh YY , et al.   Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma . Laryngoscope . 2002;112:116–119
  47. Sourvinos G , Rizos E , Spandidos DA . p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumors . Oral Oncol . 2001;37:572–578
  48. Beckman G , Birgander R , Sjalander A , et al.   Is p53 polymorphism maintained by natural selection? . Hum Hered . 1994;44:266–270
  49. Weston A , Ling-Cawley HM , Caporaso NE , et al.   Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer . Carcinogenesis . 1994;15:583–587
  50. Wu MT , Liu CL , Ho CK , et al.   Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women . J Formos Med Assoc . 2004;103:337–343

PII: S0929-6646(09)60330-2

doi: 10.1016/S0929-6646(09)60330-2

Journal of the Formosan Medical Association
Volume 105, Issue 2 , Pages 99-104 , 2006

Article Tools